selegiline has been researched along with n-methylaspartate in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (63.64) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 1 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marini, AM; Paul, SM; Weller, M | 1 |
| Danysz, W; Quack, G; Rogoz, Z; Skuza, G | 1 |
| Hsu, KS; Huang, CC; Su, MT; Tsai, JJ | 1 |
| Leonardi, EK; Mytilineou, C; Olanow, CW; Radcliffe, P; Werner, P | 1 |
| Lapin, IP; Yuwiler, A | 1 |
| Akaike, A; Katsuki, H; Shimazu, S | 1 |
| Akaike, A; Kaneko, S; Katsuki, H; Kume, T | 1 |
| Akaike, A; Honda, Y; Kashii, S; Katsuki, H; Kobayashi, Y; Kume, T; Muraoka, S; Takahata, K; Yoneda, F | 1 |
| Haapalinna, A; Niittykoski, M; Sirviö, J | 1 |
| Kinney, GG; Ransom, RW; Shughrue, PJ; Vanko, AE; West, BD | 1 |
| Büttner, T; Csoti, I; Kassubek, J; Reichmann, H; Riederer, P; Schulz, JB; Wüllner, U | 1 |
1 review(s) available for selegiline and n-methylaspartate
| Article | Year |
|---|---|
[On the role of MAO B inhibitors and NMDA antagonists in the therapy of Parkinson's disease].
Topics: Amantadine; Excitatory Amino Acid Antagonists; Humans; Indans; Memantine; Monoamine Oxidase; Monoamine Oxidase Inhibitors; N-Methylaspartate; Parkinson Disease; Piperidines; Selegiline | 2010 |
10 other study(ies) available for selegiline and n-methylaspartate
| Article | Year |
|---|---|
Niacinamide blocks 3-acetylpyridine toxicity of cerebellar granule cells in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cerebellum; Dizocilpine Maleate; Drug Synergism; Excitatory Amino Acid Antagonists; Glutamates; Glutamic Acid; Mazindol; N-Methylaspartate; Neurons; Niacinamide; Pyridines; Rats; Rats, Sprague-Dawley; Selegiline; Tetrahydrofolates | 1992 |
Memantine, amantadine, and L-deprenyl potentiate the action of L-dopa in monoamine-depleted rats.
Topics: Amantadine; Animals; Bromocriptine; Dopamine; Drug Synergism; Levodopa; Male; Memantine; Motor Activity; N-Methylaspartate; Parkinson Disease; Rats; Rats, Wistar; Selegiline | 1994 |
L-deprenyl (selegiline) decreases excitatory synaptic transmission in the rat hippocampus via a dopaminergic mechanism.
Topics: Animals; Anticonvulsants; Dopamine; Dose-Response Relationship, Drug; Glutamine; Hippocampus; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; N-Methylaspartate; Pargyline; Picrotoxin; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Selegiline; Synaptic Transmission | 1996 |
L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.
Topics: 2-Amino-5-phosphonovalerate; Animals; Cell Death; Culture Media; Dizocilpine Maleate; Dopamine; Excitatory Amino Acid Antagonists; Mesencephalon; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Neuroprotective Agents; Pargyline; Rats; Receptors, Glutamate; Selegiline | 1997 |
Modulation of the inhibitory effect of phenylethylamine on spontaneous motor activity in mice by CPP-(+/-)-3-(2-carboxypiperazin-4-YL)-propyl-1-phosphonic acid.
Topics: Animals; Brain; Dose-Response Relationship, Drug; Drug Synergism; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Male; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Motor Activity; N-Methylaspartate; Phenethylamines; Piperazines; Selegiline | 1997 |
Deprenyl rescues dopaminergic neurons in organotypic slice cultures of neonatal rat mesencephalon from N-methyl-D-aspartate toxicity.
Topics: Animals; Animals, Newborn; Cell Survival; Culture Techniques; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Hydrogen Peroxide; Immunohistochemistry; Mesencephalon; N-Methylaspartate; Neurons; Neuroprotective Agents; Oxidants; Rats; Rats, Wistar; Selegiline; Stereoisomerism; Tyrosine 3-Monooxygenase | 1999 |
[Factors regulating survival and death of midbrain dopamine neurons].
Topics: 1-Methyl-4-phenylpyridinium; Animals; Buthionine Sulfoximine; Cell Death; Culture Techniques; Dopamine; Excitatory Amino Acid Agonists; Immunohistochemistry; Monoamine Oxidase; N-Methylaspartate; Neurons; Neuroprotective Agents; Rats; Rats, Wistar; Selegiline; Substantia Nigra; Tyrosine 3-Monooxygenase | 1999 |
Protective effects of selegiline and desmethylselegiline against N-methyl-D-aspartate-induced rat retinal damage.
Topics: Amphetamines; Animals; Brain-Derived Neurotrophic Factor; Dizocilpine Maleate; Injections; Injections, Subcutaneous; Male; N-Methylaspartate; Neurons; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Retina; Selegiline; Superior Colliculi; Vitreous Body | 2003 |
Selegiline reduces N-methyl-D-aspartic acid induced perturbation of neurotransmission but it leaves NMDA receptor dependent long-term potentiation intact in the hippocampus.
Topics: Animals; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Pargyline; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Selegiline; Synaptic Transmission | 2003 |
Amphetamine-induced locomotor activity is reduced in mice following MPTP treatment but not following selegiline/MPTP treatment.
Topics: Amphetamine; Animals; Behavior, Animal; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Locomotion; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neuroprotective Agents; Selegiline | 2006 |